Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

Fig. 2

ZBTB9 genetic alteration and promoter methylation analysis. ZBTB9 alteration in pan-cancers (A). Types of ZBTB9 mutation in pan-cancers (B). Types and substitution of ZBTB9 mutation in pan-cancers (C). Correlation between promoter methylation level of ZBTB9 and clinical characteristics (D-I). (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us